Primary
ovarian carcinoid: a case report

doi:10.3760/cma.j.issn.1007-1245.2022.07.026

International Medicine and Health Guidance News ›› 2022, Vol. 28 ›› Issue (7): 996-998.DOI: 10.3760/cma.j.issn.1007-1245.2022.07.026

• Case Report • Previous Articles Next Articles

Primary ovarian carcinoid: a case report

Wang Wen¹, Tian Xiangyu², Yao Shujuan³

¹Department of Obstetrics and Gynecology, Tengzhou Central People's Hospital, Tengzhou 277599, China; ²Department of Medical Image Center, Tengzhou Central People's Hospital, Tengzhou 277599, China; ³Department of Obstetrics and Gynecology, Hospital Affiliated to Shandong University of Traditional Chinese Medicine, Jinan 250011, China

Received:2021-12-07 Online:2022-04-01 Published:2022-05-06
Contact: Yao Shujuan, Email: sdzztzysj@tom.com
Supported by:
Project of Development Plan of Medical and Health Science and Technology in Shandong Province (202105010540)

原发性卵巢类癌1例

王稳¹ 田翔宇² 姚淑娟³

¹滕州市中心人民医院妇产科，滕州　277599； ²滕州市中心人民医院医学影像中心，滕州　277599； ³山东中医药大学附属医院妇产科，济南　250011

通讯作者: 姚淑娟，Email：sdzztzysj@tom.com
基金资助:
山东省医药卫生科技发展计划项目（202105010540）

Abstract

Abstract: Primary ovarian carcinoid is rare, mostly occurring in perimenopausal women. At present, most cases are reported as individual cases. Gynecologists have not much knowledge of it, and it is difficult to diagnose before surgery. Its diagnosis is mainly confirmed by postoperative pathological examination. It could be misdiagnosed easily. The disease should be highly suspected when pelvic mass is found clinically, as well as the occurrence of certain endocrine substances and their causes of skin flushing, telangiectasia, bronchospasm, heart damage, and other symptoms. The surgical scope can be selected individually according to the patients' age, fertility requirements, and other specific conditions. These patients should be strictly followed up after surgery.

Key words: Carcinoid, Malignant carcinoid syndrome, Primary ovarian carcinoid

摘要： 原发性卵巢类癌十分罕见，多发生于围绝经期女性，目前多为病例个案报道，妇科医生对其认识相对较少，术前不易诊断，主要依靠术后病理检查明确诊断，易引起误诊。临床发现盆腔包块，以及出现某些内分泌物质及其引起的皮肤潮红、毛细血管扩张、支气管痉挛、心脏损害等症候群，应高度怀疑该病。手术范围可根据患者的年龄、生育要求等具体情况个体化选择，术后均应严密随访。

关键词: 类癌, 类癌综合征, 原发性卵巢类癌

Wang Wen, Tian Xiangyu, Yao Shujuan.

Primary ovarian carcinoid: a case report [J]. International Medicine and Health Guidance News, 2022, 28(7): 996-998.

王稳, 田翔宇, 姚淑娟. 原发性卵巢类癌1例[J]. 国际医药卫生导报, 2022, 28(7): 996-998.

References

[1] Linhas R, Tente D, China N, et al. Subcutaneous metastasis of a pulmonary carcinoid tumor:a case report[J]. Medicine (Baltimore),2018,97(2):e9415. DOI: 10.1097/MD.0000000000009415.

[2] Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the united states[J]. JAMA Oncol,2017,3(10):1335-1342. DOI: 10.1001/jamaoncol. 2017.0589.

[3] Zhai LR, Zhang XW, YU T, et al. Primary ovarian carcinoid: two cases report and review of literature[J].Medicine(Baltimore),2020,99(40):e21109. DOI: 10.1097/MD.0000000000021109.

[4] Fiore MG, Rossi R, Covelli C, et al. Goblet-cell carcinoid of the ovary: A case report with ultrastructural analysis[J]. J Obstet Gynaecol, 2017,37(2):266-267. DOI: 10.1080/01443615.2016.1244806.

[5] Noh HK, Kwon BS, Kim YH, et al. Peptide YY producing strumal carcinoid tumor of the ovary in a postmenopausal woman: a rare cause of chronic constipation[J]. Obstet Gynecol Sci, 2017,60(6):602-607. DOI: 10.5468/ogs.2017.60.6.602.

[6] Soga J, Osaka M, Yakuwa Y. Carcinoids of the ovary: an analysis of 329 reported cases[J]. J Exp Clin Cancer Res, 2000,19(3):271-280.

[7] 连利娟.林巧稚妇科肿瘤学[M].北京:人民卫生出版社,2006:601-607.

[8] 邓姗,潘凌亚,黄惠芳,等.卵巢甲状腺肿类癌三例报告并文献复习[J].中华妇产科杂志,2003,38(4):243-244.DOI:10.3760/j.issn:0529-567X.2003.04.019.

[9] 史晨辰,吴燕.原发性卵巢类癌二例[J].中国妇产科临床杂志,2014,15(5):464-465.DOI:10.13390/j.issn.1672-1861. 2014.05.028.

[10] 王晨晨,宋芳,肖川,等.卵巢甲状腺肿类癌临床病理特征并文献复习[J].中华肿瘤防治杂志,2020,27(19):1590-1597.DOI:10.16073/j.cnki.cjcpt.2020.19.10.

[11] Howitt BE, Kelly P, McCluggage WG. Pathology of neuroendocrine tumours of the female genital tract[J]. Curr Oncol Rep, 2017,19(9):59. DOI: 10.1007/s11912- 017-0617-2.

[12] Vora M, Lacour RA, Black DR, et al. Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation[J]. Arch Gynecol Obstet, 2016,293(3):659-665. DOI: 10.1007/s00404- 015-3865-0.

[13] Gardner GJ, Reidy-Lagunes D, Gehrig PA. Neuroendocrine tumors of the gynecologic tract: a Society of Gynecologic Oncology (SGO) clinical document[J]. Gynecol Oncol, 2011,122(1):190-198. DOI: 10.1016/j.ygyno.2011.04.011.

[14] Davis KP, Hartmann LK, Keeney GL, et al. Primary ovarian carcinoid tumors[J]. Gynecol Oncol, 1996,61(2):259-265. DOI: 10.1006/gyno.1996.0136.

[15] Wright JD, Matsuo K, Huang Y, et al. Prognostic performance of the 2018 international federation of gynecology and obstetrics cervical cancer staging guidelines[J]. Obstet Gynecol, 2019,134(1):49-57. DOI: 10.1097/AOG.0000000000003311.

[16] Kaiho-Sakuma M, Toyoshima M, Watanabe M, et al. Aggressive neuroendocrine tumor of the ovary with multiple metastases treated with everolimus: a case report[J]. Gynecol Oncol Rep, 2018,23:20-23. DOI: 10.1016/j.gore.2018.01.002.

[17] 吴震溟,狄文.卵巢类癌1例报道[J].肿瘤防治研究,2005,32(10):671. DOI:10.3971/j.issn.1000-8578.2459.

[18] Hayashi T, Haba R, Kushida Y, et al. Cytopathologic characteristics of the primary strumal carcinoid tumor of the ovary: a case report with emphasis on differential diagnostic considerations[J]. Diagn Cytopathol, 2013,41(9):812-816. DOI: 10.1002/dc.22811.

[19] Spaulding R, Alatassi H, Stewart Metzinger D, et al. Ependymoma and carcinoid tumor associated with ovarian mature cystic teratoma in a patient with multiple endocrine neoplasia I[J]. Case Rep Obstet Gynecol, 2014,2014:712657. DOI: 10.1155/2014/712657.

[20] Reed NS, Gomez-Garcia E, Gallardo-Rincon D, et al. Gynecologic Cancer InterGroup (GCIG) consensus review for carcinoid tumors of the ovary[J]. Int J Gynecol Cancer, 2014,24(9 Suppl 3):S35-41. DOI: 10.1097/IGC.0000000000000265.

Primary ovarian carcinoid: a case report

原发性卵巢类癌1例

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 0

Recommended Articles

Metrics